Skip to main content
. 2011 Dec 19;119(7):1665–1670. doi: 10.1182/blood-2011-10-388058

Table 3.

EFS: intent-to-treat cohort (single variable analysis)

Factor P (log-rank)
Risk factors (0 and 1 vs 2) .01
Bulky > 5 cm .047
FDG-PET (positive vs negative) < .0001
Extranodal sites .037
Relapse/refractory .079
B symptoms .699